The most frequently mutated oncogenes and primary molecular targets in NSCLC include epidermal growth factor receptor (EGFR), Kirsten rat sarcoma viral oncogene (KRAS), and anaplastic lymphoma kinase (ALK) [79]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.